Bleeds in acquired hemophilia A safely prevented with Hemlibra
Hemlibra (emicizumab) effectively prevented bleeds in patients with acquired hemophilia A (AHA), according to real-world data from a…
Articles by Patricia Inácio, PhD
Prophylaxis able to reduce bleeds in older people with severe hemophilia
Preventive therapy, or prophylaxis, in patients ages 50 and older with severe hemophilia type A and type B…
Gene therapy Hemgenix given to 1st hemophilia B patient in Nevada
A 39-year-old man from Arizona became the first patient in Nevada to receive Hemgenix (etranacogene dezaparvovec), the first gene…
2 patients in France get hemophilia B gene therapy Hemgenix
Hemgenix (etranacogene dezaparvovec), the first approved hemophilia B gene therapy, has been successfully administered to two patients in…
Patient survey: Florio Haemo smartphone app reliable, easy to use
Most caregivers or patients with hemophilia who were on preventive treatment were satisfied or very satisfied with the…
Hemlibra is safe, effective in older patients with other conditions
The efficacy and safety profiles of preventive treatment with Hemlibra (emicizumab-KXWH) are not affected by age or the presence…
Review study shows prevalence, impact of hemophilia in Brazil
In Brazil, hemophilia markedly impairs patients’ quality of life and ability to work, with up to 82.6% of people…
Mim8 seen as better than standard hem A therapies at bleed control
Weekly and monthly treatment with Mim8, an investigational antibody therapy, was seen to be better than on-demand or standard preventive…
GeneVentiv receives $2.5M grant for hemophilia gene therapy
GeneVentiv Therapeutics has received a $2.5 million grant to conduct further preclinical tests on its one-time infusion gene therapy…
Activity wristbands may help men with severe hemophilia: Study
Men with severe hemophilia who wore activity wristbands to self-manage their physical activity saw significant improvements in their physical…